Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

Clene’s President and Chief Executive Officer Rob Etherington discusses the company’s innovative technology and its potential to address the underlying causes of neurodegenerative diseases.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: